EASL recommendations on treatment of hepatitis C: Final update of the series( ).
European Association for the Study of the Liver; Clinical Practice Guidelines Panel: Chair:; EASL Governing Board representative:; Panel members:.
J Hepatol. 2020 Nov;73(5):1170-1218. doi: 10.1016/j.jhep.2020.08.018. Epub 2020 Sep 15.
Viral hepatitis C.
Poynard T, Yuen MF, Ratziu V, Lai CL.
Lancet. 2003 Dec 20;362(9401):2095-100. doi: 10.1016/s0140-6736(03)15109-4.
[Chronic hepatitis C: patients with mild disease].
Quer JC, Diago M, Crespo J, García-Samaniego J, Morillas R, Andrade R, Ángel Simón M.
Gastroenterol Hepatol. 2014 Jul;37 Suppl 1:3-12. doi: 10.1016/S0210-5705(15)30002-9.
Liver biopsy in the post-hepatitis C virus era in Japan.
Ikura Y, Okubo T, Sakai Y.
World J Gastroenterol. 2024 Apr 14;30(14):1949-1957. doi: 10.3748/wjg.v30.i14.1949.
Lymphocyte Landscape after Chronic Hepatitis C Virus (HCV) Cure: The New Normal.
Ghosh A, Romani S, Kottilil S, Poonia B.
Int J Mol Sci. 2020 Oct 10;21(20):7473. doi: 10.3390/ijms21207473.
Thrombocytopenia in chronic hepatitis C.
Olariu M, Olariu C, Olteanu D.
J Gastrointestin Liver Dis. 2010 Dec;19(4):381-5.
Hepatitis C virus biology.
Giannini C, Bréchot C.
Cell Death Differ. 2003 Jan;10 Suppl 1:S27-38. doi: 10.1038/sj.cdd.4401121.
Rheumatic manifestations of hepatitis C virus chronic infection: Indications for a correct diagnosis.
Palazzi C, D'Amico E, D'Angelo S, Gilio M, Olivieri I.
World J Gastroenterol. 2016 Jan 28;22(4):1405-10. doi: 10.3748/wjg.v22.i4.1405.
Hepatitis C and alcohol.
Schiff ER.
Hepatology. 1997 Sep;26(3 Suppl 1):39S-42S. doi: 10.1002/hep.510260707.
Hepatitis C: From inflammatory pathogenesis to anti-inflammatory/hepatoprotective therapy.
Li H, Huang MH, Jiang JD, Peng ZG.
World J Gastroenterol. 2018 Dec 21;24(47):5297-5311. doi: 10.3748/wjg.v24.i47.5297.
